Vyberte zemi nebo region

Nyní se nacházíte v části Czech Republic (Česky)
Arjo Andreas Elgaard Q4.jpg

Year-end report 2025

"Global demand is stable and despite a somewhat weaker end than expected we are growing in line with our target, which remains unchanged again for 2026. Profitability did not perform at the level we would have liked, with headwinds from currencies, tariffs and mix effects. At the same time, the trend in cash flow was positive and we are just below the 80% cash conversion target for the full-year. There is significant potential to further strengthen our market position, offering, and efficiency going forward. We are now launching the work to develop a new strategy for Arjo, together with our employees, and to ensure its successful execution."

 

- Andréas Elgaard, President and CEO

Arjo_AR24_coverimage.png

Annual and Sustainability Report 2024

Contributing to more sustainable healthcare is the core of Arjo’s business model. We have seen how increased patient mobility can quickly improve both clinical and financial outcomes. As leading specialists in the field, our role is to make more highquality care available to more people. Together with our customers and partners, we are part of shaping the future of healthcare.

A sustainable healthcare – the core of our business

Research shows that there is a clear connection between mobility and people’s physical and mental well-being. We have seen how increased patient mobility can quickly improve both clinical and financial outcomes. As leading specialists in the field our role is to make more high-quality care available to more people, and thereby contribute to a sustainable healthcare.

Calendar icon blue

Founded by Arne Johansson in Eslöv in 1957

Team group icon blue

Approximately 7 000 employees

Globe icon blue

Sells solutions and products in more than 100 countries

Leaf environment icon blue

Contributes to sustainable healthcare

Positive line chart icon blue

Net sales of about SEK 11 billion in 2024

Office icon blue

Five product development and production units worldwide

Rehab Final 376_376.jpg

Investment case

Over the years, Arjo has built up extensive expertise and developed market-leading solutions that contribute to increased safety and quality of life for patients, improved work environment for healthcare staff and better resource efficiency for healthcare providers. With the healthcare sector facing significant challenges, Arjo is well-positioned to contribute to long-term sustainable care.

AGM2025.jpg

2026

Annual General Meeting

Arjo AB's Annual General Meeting will be held on April 22th, 2026.

hands with mouse and Arjo cup

Subscribe

Register here to receive our press releases, financial reports and more.

qreportinvestor_final.jpg

Financial reports and presentations

shareiconinvestor.jpg

The Arjo share

Information about the major shareholders, share price, dividend and total return as well as analysts.

Maria Nilsson AMT New.jpg

Contact

Maria Nilsson
EVP Communications & Public Relations

Erik Roslund web.jpg

Contact

Erik Roslund
Investor Relations & Corporate Communications Manager

More information

Potvrzuji, že jsem se seznámil s definicí odborníka ve smyslu zákona č. 40/1995 Sb. a že jsem tímto odborníkem.

Kliknutím na tlačítko ANO chci pokračovat na tyto webové stránky a výslovně potvrzuji následující:

  • Jsem odborníkem, tedy osobou oprávněnou předepisovat nebo vydávat zdravotnické prostředky nebo diagnostické zdravotnické prostředky in vitro, případně zaměstnancem poskytovatele zdravotnických služeb.
  • Je mi známa definice odborníka, případně vymezení zaměstnance poskytovatele zdravotnických služeb ve smyslu zákona č. 40/1995 Sb.
  • Beru na vědomí, že informace obsažené na těchto webových stránkách nejsou určeny pro laickou veřejnost, ale pouze pro odborníky a zaměstnance poskytovatelů zdravotnických služeb. Dále potvrzuji, že jsou mi známa rizika spojená s návštěvou těchto webových stránek jinou osobou než odborníkem nebo zaměstnancem poskytovatele zdravotnických služeb (např. neporozumění správnému fungování inzerovaných zdravotnických prostředků, nesprávný výběr zdravotnického prostředku nebo nesprávné učinění diagnózy).